BioTelemetry, Inc. 4
4 · BioTelemetry, Inc. · Filed Nov 26, 2013
Insider Transaction Report
Form 4
PRYSTOWSKY ERIC N
Director
Transactions
- Exercise/Conversion
Common Stock
2013-11-22$6.10/sh+10,000$61,000→ 135,706 total - Exercise/Conversion
Common Stock
2013-11-22$9.50/sh+1,250$11,875→ 126,956 total - Exercise/Conversion
Stock Option (right to buy)
2013-11-22−10,000→ 0 totalExercise: $6.10Exp: 2017-04-17→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2013-11-22$7.20/sh+16,250$117,000→ 141,956 total - Sale
Common Stock
2013-11-22$10.65/sh−16,250$173,144→ 125,706 total - Exercise/Conversion
Stock Option (right to buy)
2013-11-22−1,250→ 0 totalExercise: $9.50Exp: 2017-11-16→ Common Stock (1,250 underlying) - Sale
Common Stock
2013-11-22$10.65/sh−1,250$13,319→ 125,706 total - Sale
Common Stock
2013-11-22$10.65/sh−10,000$106,550→ 125,706 total - Gift
Common Stock
2013-11-22−6,000→ 119,706 total - Exercise/Conversion
Stock Option (right to buy)
2013-11-22−16,250→ 0 totalExercise: $7.20Exp: 2017-09-24→ Common Stock (16,250 underlying)
Footnotes (4)
- [F1]The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices and ranges from $10.53-$10.82, inclusive. The reporting person undertakes to provide to BioTelemtry, Inc., any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
- [F2]The option vested in one installment on April 19, 2007
- [F3]The option vested as follows: 5,000 shares vested on September 24 2007 and the remaining 10,000 shares vested proportionately over the subsequent 24 months
- [F4]The option vested in one installment on November 16, 2007